{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:37:27Z","timestamp":1790861847419,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Swedish Brain Foundatio","award":["FO2023-0223"],"award-info":[{"award-number":["FO2023-0223"]}]},{"name":"Swedish Brain Foundatio","award":["FO2023-0223"],"award-info":[{"award-number":["FO2023-0223"]}]},{"name":"Swedish Brain Foundatio","award":["FO2023-0223"],"award-info":[{"award-number":["FO2023-0223"]}]},{"name":"Swedish Brain Foundatio","award":["FO2023-0223"],"award-info":[{"award-number":["FO2023-0223"]}]},{"name":"Swedish Brain Foundatio","award":["FO2023-0223"],"award-info":[{"award-number":["FO2023-0223"]}]},{"name":"Mellby G\u00e5rd Foundation"},{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cluster headache is characterized by activation of the trigeminovascular pathway with subsequent pain signalling in the meningeal vessels, and inflammation has been suggested to play a role in the pathophysiology. To further investigate inflammation in cluster headache, inflammatory markers were analysed in patients with cluster headache and controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a case\u2013control study, collecting cerebrospinal fluid and serum samples from healthy controls, cluster headache patients in remission, active bout, and during an attack to cover the dynamic range of the cluster headache phenotype. Inflammatory markers were quantified using Target 48 OLINK cytokine panels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Altered levels of several cytokines were found in patients with cluster headache compared to controls. CCL8, CCL13, CCL11, CXCL10, CXCL11, HGF, MMP1, TNFSF10 and TNFSF12 levels in cerebrospinal fluid were comparable in active bout and remission, though significantly higher than in controls. In serum samples, CCL11 and CXCL11 displayed decreased levels in patients. Only one cytokine, IL-13 was differentially expressed in serum during attacks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion and interpretation<\/jats:title>\n                    <jats:p>Our data shows signs of possible neuroinflammation occurring in biological samples from cluster headache patients. Increased cerebrospinal fluid cytokine levels are detectable in active bout and during remission, indicating neuroinflammation could be considered a marker for cluster headache and is unrelated to the different phases of the disorder.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s10194-024-01829-9","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T08:02:56Z","timestamp":1721721776000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Elevated cytokine levels in the central nervous system of cluster headache patients in bout and in remission"],"prefix":"10.1186","volume":"25","author":[{"given":"Caroline","family":"Ran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia Jennysdotter","family":"Olofsg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Wellfelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Steinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Carmine","family":"Belin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,23]]},"reference":[{"key":"1829_CR1","doi-asserted-by":"crossref","unstructured":"The International Headache Society. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38:1\u2013211.","DOI":"10.1177\/0333102417738202"},{"key":"1829_CR2","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41582-021-00477-w","volume":"17","author":"DY Wei","year":"2021","unstructured":"Wei DY, Goadsby PJ (2021) Cluster headache pathophysiology \u2014 insights from current and emerging treatments. Nat Rev Neurol 17:308\u2013324","journal-title":"Nat Rev Neurol"},{"key":"1829_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1046\/j.1468-2982.1987.0703207.x","volume":"7","author":"J Hannerz","year":"1987","unstructured":"Hannerz J, Ericson K, Bergstrand G (1987) Orbital phlebography in patients with cluster headache. Cephalalgia 7:207\u2013211","journal-title":"Cephalalgia"},{"key":"1829_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1474-4422(20)30363-X","volume":"20","author":"J-P Jansen","year":"2021","unstructured":"Jansen J-P, Obermann M, N\u00e4gel S et al (2021) Safety and efficacy of prednisone versus placebo in short-term prevention of episodic cluster headache: a multicentre, double-blind, randomised controlled trial. Articles Lancet Neurol 20:29\u201337","journal-title":"Articles Lancet Neurol"},{"key":"1829_CR5","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1046\/j.1526-4610.2000.00041.x","volume":"40","author":"IN Remahl","year":"2000","unstructured":"Remahl IN, Waldenlind E, Bratt J et al (2000) Cluster headache is not associated with signs of a systemic inflammation. Headache 40:276\u2013282","journal-title":"Headache"},{"key":"1829_CR6","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1111\/j.1526-4610.2006.00611.x","volume":"46","author":"C Sjostrand","year":"2006","unstructured":"Sjostrand C, Duvefelt K, Steinberg A et al (2006) Gene expression profiling in cluster headache: a pilot microarray study. Headache 46:1518\u20131534","journal-title":"Headache"},{"key":"1829_CR7","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1111\/head.14334","volume":"62","author":"E \u015eahin","year":"2022","unstructured":"\u015eahin E, Karaaslan Z, \u015eanl\u0131 E et al (2022) Reduced expression of inflammasome complex components in cluster headache. Headache 62:967\u2013976","journal-title":"Headache"},{"key":"1829_CR8","doi-asserted-by":"publisher","first-page":"40218","DOI":"10.1038\/srep40218","volume":"7","author":"E Eising","year":"2017","unstructured":"Eising E, Pelzer N, Vijfhuizen LS et al (2017) Identifying a gene expression signature of cluster headache in blood. Sci Rep 7:40218","journal-title":"Sci Rep"},{"key":"1829_CR9","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/j.1600-0404.2010.01434.x","volume":"124","author":"A Steinberg","year":"2011","unstructured":"Steinberg A, Sj\u00f6strand C, Sominanda A et al (2011) Interleukin-2 gene expression in different phases of episodic cluster headache \u2013 a pilot study. Acta Neurol Scand 124:130\u2013134","journal-title":"Acta Neurol Scand"},{"key":"1829_CR10","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1046\/j.1468-2982.1993.1305343.x","volume":"13","author":"P Martelletti","year":"1993","unstructured":"Martelletti P, Granata M, Giacovazzo M (1993) Serum Interleukin-1 Beta is Increased in Cluster Headache. Cephalalgia 13:343\u2013345","journal-title":"Cephalalgia"},{"key":"1829_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s10194-023-01572-7","volume":"24","author":"AK Musubire","year":"2023","unstructured":"Musubire AK, Cheema S, Ray JC et al (2023) Cytokines in primary headache disorders: a systematic review and meta-analysis. J Headache Pain 24:36","journal-title":"J Headache Pain"},{"key":"1829_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1046\/j.1526-4610.2003.03011.x","volume":"43","author":"M Empl","year":"2003","unstructured":"Empl M, F\u00f6rderreuther S, Schwarz M et al (2003) Soluble interleukin-2 receptors increase during the active periods in cluster headache. Headache 43:63\u201368","journal-title":"Headache"},{"key":"1829_CR13","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/ana.26743","volume":"94","author":"BS Winsvold","year":"2023","unstructured":"Winsvold BS, Harder AVE, Ran C et al (2023) Cluster Headache Genomewide Association Study and Meta-Analysis Identifies Eight Loci and Implicates Smoking as Causal Risk Factor. Ann Neurol 94:713\u2013726","journal-title":"Ann Neurol"},{"key":"1829_CR14","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M et al (2023) The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res 51:D638\u2013D646","journal-title":"Nucleic Acids Res"},{"key":"1829_CR15","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1111\/febs.14466","volume":"285","author":"CE Hughes","year":"2018","unstructured":"Hughes CE, Nibbs RJB (2018) A guide to chemokines and their receptors. FEBS J 285:2944","journal-title":"FEBS J"},{"key":"1829_CR16","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/ana.24665","volume":"79","author":"C Perry","year":"2016","unstructured":"Perry C, Blake P, Buettner C et al (2016) Upregulation of inflammatory gene transcripts in periosteum of chronic migraineurs: implications to extracranial origin of headache HHS Public Access Author manuscript. Ann Neurol 79:1000\u20131013","journal-title":"Ann Neurol"},{"key":"1829_CR17","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.pain.2014.04.019","volume":"155","author":"J Zhao","year":"2014","unstructured":"Zhao J, Levy D (2014) The sensory innervation of the calvarial periosteum is nociceptive and contributes to headache-like behavior. Pain 155:1392\u20131400","journal-title":"Pain"},{"key":"1829_CR18","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/j.1468-2982.2008.01727.x","volume":"29","author":"SH B\u00f8","year":"2009","unstructured":"B\u00f8 SH, Davidsen EM, Gulbrandsen P et al (2009) Cerebrospinal fluid cytokine levels in migraine, tension-type headache and cervicogenic headache. Cephalalgia 29:365\u2013372","journal-title":"Cephalalgia"},{"key":"1829_CR19","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/jlb.61.3.246","volume":"61","author":"JM Farber","year":"1997","unstructured":"Farber JM (1997) Mig and IP-10: CXC chemokines that target lymphocytes. J Leukoc Biol 61:246\u2013257","journal-title":"J Leukoc Biol"},{"key":"1829_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/aps.2008.24","volume":"30","author":"JM Gao","year":"2009","unstructured":"Gao JM, Xiang RL, Jiang L et al (2009) Sulfated tyrosines 27 and 29 in the N-terminus of human CXCR3 participate in binding native IP-10. Acta Pharmacologica Sinica 30:193\u2013201","journal-title":"Acta Pharmacologica Sinica"},{"key":"1829_CR21","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1182\/blood-2002-12-3945","volume":"102","author":"MJ Smit","year":"2003","unstructured":"Smit MJ, Verdijk P, Van der Raaij-Helmer EMH et al (2003) CXCR3-mediated chemotaxis of human T cells is regulated by a Gi- and phospholipase C\u2013dependent pathway and not via activation of MEK\/p44\/p42 MAPK nor Akt\/PI-3 kinase. Blood 102:1959\u20131965","journal-title":"Blood"},{"key":"1829_CR22","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.4049\/jimmunol.1401459","volume":"194","author":"T Clarner","year":"2015","unstructured":"Clarner T, Janssen K, Nellessen L et al (2015) CXCL10 triggers early microglial activation in the cuprizone model. J Immunol 194:3400\u20133413","journal-title":"J Immunol"},{"key":"1829_CR23","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S0165-5728(03)00009-2","volume":"136","author":"G Flynn","year":"2003","unstructured":"Flynn G, Maru S, Loughlin J et al (2003) Regulation of chemokine receptor expression in human microglia and astrocytes. J Neuroimmunol 136:84\u201393","journal-title":"J Neuroimmunol"},{"key":"1829_CR24","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1161\/01.RES.67.2.469","volume":"67","author":"T Kuga","year":"1990","unstructured":"Kuga T, Sadoshima J, Tomoike H et al (1990) Actions of Ca2+ antagonists on two types of Ca2+ channels in rat aorta smooth muscle cells in primary culture. Circ Res 67:469\u2013480","journal-title":"Circ Res"},{"key":"1829_CR25","doi-asserted-by":"publisher","first-page":"709","DOI":"10.3390\/cells8070709","volume":"8","author":"V Volarevic","year":"2019","unstructured":"Volarevic V, Zdravkovic N, Harrell CR et al (2019) Galectin-3 regulates indoleamine-2, 3-dioxygenase-dependent cross-talk between colon-infiltrating dendritic cells and T regulatory cells and may represent a valuable biomarker for monitoring the progression of ulcerative colitis. Cells 8:709","journal-title":"Cells"},{"key":"1829_CR26","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s10194-024-01791-6","volume":"25","author":"JCA Edvinsson","year":"2024","unstructured":"Edvinsson JCA, Ran C, Olofsg\u00e5rd FJ et al (2024) MERTK in the rat trigeminal system: a potential novel target for cluster headache? J Headache Pain 25:85","journal-title":"J Headache Pain"},{"key":"1829_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/2727042","volume":"2020","author":"E Martynova","year":"2020","unstructured":"Martynova E, Goyal M, Johri S et al (2020) Serum and Cerebrospinal Fluid Cytokine Biomarkers for Diagnosis of Multiple Sclerosis. Mediators Inflamm 2020:1\u201310","journal-title":"Mediators Inflamm"},{"key":"1829_CR28","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.cyto.2016.12.025","volume":"98","author":"R Imamura","year":"2017","unstructured":"Imamura R, Matsumoto K (2017) Hepatocyte growth factor in physiology and infectious diseases. Cytokine 98:97\u2013106","journal-title":"Cytokine"},{"key":"1829_CR29","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/hr.2014.41","volume":"37","author":"H Kusunoki","year":"2014","unstructured":"Kusunoki H, Taniyama Y, Otsu R et al (2014) Anti-inflammatory effects of hepatocyte growth factor on the vicious cycle of macrophages and adipocytes. Hypertens Res 37:500\u2013506","journal-title":"Hypertens Res"},{"key":"1829_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-023-46797-3","volume":"13","author":"C Fu","year":"2023","unstructured":"Fu C, Chen Y, Xu W et al (2023) Exploring the causal relationship between inflammatory cytokines and migraine: a bidirectional, two-sample Mendelian randomization study. Sci Rep 13:1\u20139","journal-title":"Sci Rep"},{"key":"1829_CR31","doi-asserted-by":"publisher","first-page":"12414","DOI":"10.1523\/JNEUROSCI.3135-10.2010","volume":"30","author":"E Gascon","year":"2010","unstructured":"Gascon E, Gaillard S, Malapert P et al (2010) Hepatocyte Growth Factor-Met Signaling Is Required for Runx1 Extinction and Peptidergic Differentiation in Primary Nociceptive Neurons. J Neurosci 30:12414\u201312423","journal-title":"J Neurosci"},{"key":"1829_CR32","doi-asserted-by":"publisher","first-page":"7085","DOI":"10.1007\/s12035-019-1545-y","volume":"56","author":"LN Huang","year":"2019","unstructured":"Huang LN, Zou Y, Wu SG et al (2019) Fn14 Participates in Neuropathic Pain Through NF-\u03baB Pathway in Primary Sensory Neurons. Mol Neurobiol 56:7085\u20137096","journal-title":"Mol Neurobiol"},{"key":"1829_CR33","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.semcdb.2007.07.003","volume":"19","author":"AM Manicone","year":"2008","unstructured":"Manicone AM, Mcguire JK (2008) Matrix metalloproteinases as modulators of inflammation. Semin Cell Dev Biol 19:34\u201341","journal-title":"Semin Cell Dev Biol"},{"key":"1829_CR34","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1526-4610.2007.00958.x","volume":"48","author":"K Imamura","year":"2008","unstructured":"Imamura K, Takeshima T, Fusayasu E et al (2008) Increased Plasma Matrix Metalloproteinase-9 Levels in Migraineurs. Headache 48:135\u2013139","journal-title":"Headache"},{"key":"1829_CR35","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.pain.2014.01.026","volume":"155","author":"TKY Lim","year":"2014","unstructured":"Lim TKY, Shi XQ, Martin HC et al (2014) Blood-nerve barrier dysfunction contributes to the generation of neuropathic pain and allows targeting of injured nerves for pain relief. Pain 155:954\u2013967","journal-title":"Pain"},{"key":"1829_CR36","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.nbd.2014.08.012","volume":"71","author":"RP Hulse","year":"2014","unstructured":"Hulse RP, Beazley-Long N, Hua J et al (2014) Regulation of alternative VEGF-A mRNA splicing is a therapeutic target for analgesia. Neurobiol Dis 71:245\u2013259","journal-title":"Neurobiol Dis"},{"key":"1829_CR37","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1212\/WNL.0b013e31826170ce","volume":"79","author":"X Rodr\u00edguez-Osorio","year":"2012","unstructured":"Rodr\u00edguez-Osorio X, Sobrino T, Brea D et al (2012) Endothelial progenitor cells: A new key for endothelial dysfunction in migraine. Neurology 79:474\u2013479","journal-title":"Neurology"},{"key":"1829_CR38","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/head.14641","volume":"64","author":"MLK S\u00f8borg","year":"2024","unstructured":"S\u00f8borg MLK, Jensen RH, Barloese M et al (2024) Biomarkers in cluster headache: A systematic review. Headache 64:98\u2013116","journal-title":"Headache"},{"key":"1829_CR39","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1177\/0333102419837154","volume":"39","author":"A Snoer","year":"2019","unstructured":"Snoer A, Vollesen ALH, Beske RP et al (2019) Calcitonin-gene related peptide and disease activity in cluster headache. Cephalalgia 39:575\u2013584","journal-title":"Cephalalgia"},{"key":"1829_CR40","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1177\/03331024211056248","volume":"42","author":"L Pellesi","year":"2022","unstructured":"Pellesi L, Chaudhry BA, Vollesen ALH et al (2022) PACAP38- and VIP-induced cluster headache attacks are not associated with changes of plasma CGRP or markers of mast cell activation. Cephalalgia 42:687\u2013695","journal-title":"Cephalalgia"},{"key":"1829_CR41","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1378\/chest.117.4.1162","volume":"117","author":"SM Opal","year":"2000","unstructured":"Opal SM, DePalo VA (2000) Anti-Inflammatory Cytokines. Chest 117:1162\u20131172","journal-title":"Chest"},{"key":"1829_CR42","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1007\/s13311-019-00761-0","volume":"16","author":"N Kolosowska","year":"2019","unstructured":"Kolosowska N, Keuters MH, Wojciechowski S et al (2019) Peripheral Administration of IL-13 Induces Anti-inflammatory Microglial\/Macrophage Responses and Provides Neuroprotection in Ischemic Stroke. Neurotherapeutics 16:1304","journal-title":"Neurotherapeutics"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-024-01829-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-024-01829-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-024-01829-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T09:02:08Z","timestamp":1721725328000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-024-01829-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,23]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1829"],"URL":"https:\/\/doi.org\/10.1186\/s10194-024-01829-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4610858\/v1","asserted-by":"object"}]},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,23]]},"assertion":[{"value":"20 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical permit was obtained from the Swedish Ethical Review Authority prior to the study (diary number 217\/02). Informed consent was obtained from all study participants and experiments were conducted in accordance with the declaration of Helsinki for research involving human subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"121"}}